C4 Therapeutics
CCCC
$6.74
Share price
4.82%
Change (1 day)
114.65%
Change (1 year)
Categories
Earnings for C4 Therapeutics (CCCC)
Earnings in 2023 (TTM): -$0.13 B
According to C4 Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.13 B. In 2022 the company made an earning of -$0.13 B a decrease over its 2021 earnings that were of -$81.75 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for C4 Therapeutics from 2020 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.13 B | 3.08% |
| 2022 | -$0.13 B | 54.08% |
| 2021 | -$81.75 M | 25.35% |
| 2020 | -$65.22 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | -14.68% | 🇺🇸 USA |